Masahiro Goto

7PUBLICATIONS
73CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 09, 2025
Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study.

Kentaro Sawada, Riu Yamashita, Shunsuke A Sakai

|Apr 10, 2025
Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study.

Takao Fujisawa, Yoshiaki Nakamura, Hideaki Bando

|Aug 07, 2024
Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease Assay.

Yoshiaki Nakamura, Yuichiro Tsukada, Nobuhisa Matsuhashi

|Jun 21, 2023
Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy.

Yu Aoki, Yoshiaki Nakamura, Tadamichi Denda

|Mar 30, 2023
Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program.

Yoshiaki Nakamura, Riu Yamashita, Wataru Okamoto

|Aug 27, 2021
Cancer Cachexia: Its Mechanism and Clinical Significance.

Hiroki Nishikawa, Masahiro Goto, Shinya Fukunishi

Pageof 2

Frequent Collaborators

6 joint publications

Eiji Oki

6 joint publications

Takayuki Yoshino

5 joint publications

Hideaki Bando

5 joint publications

Yoshiaki Nakamura